Sorrento Therapeutics saw the highest growth of 179% in patent filings and 699% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 179% and grants by 699%. GlobalData’s DataBook provides a comprehensive analysis of Sorrento Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Sorrento Therapeutics has been focused on protecting inventions in United States(US) with nine publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 14% filings and 42% grants. The Japan(JP), United States(US), China(CN), and Australia(AU) patent Office are among the top ten patent offices where Sorrento Therapeutics is filings its patents. Among the top granted patent authorities, Sorrento Therapeutics has 42% of its grants in United States(US), 25% in China(CN) and 8% in Japan(JP).

F. Hoffmann-La Roche could be the strongest competitor for Sorrento Therapeutics

Patents related to Covid-19 and nanomedicine lead Sorrento Therapeutics's portfolio

Sorrento Therapeutics has the highest number of patents in Covid-19 followed by, nanomedicine and rare diseases. For Covid-19, nearly 38% of patents were filed and no patents were granted in Q1 2024.

Drug delivery devices related patents lead Sorrento Therapeutics portfolio followed by viral infections, and coronavirus disease 2019 (covid-19)

Sorrento Therapeutics has highest number of patents in drug delivery devices followed by viral infections, coronavirus disease 2019 (covid-19), prostate cancer, and manufacturing/industrial. For drug delivery devices, nearly 6% of patents were filed and 15% of patents were granted in Q1 2024.

For comprehensive analysis of Sorrento Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.